Jiangtao Lai
Overview
Explore the profile of Jiangtao Lai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shu Z, Chen M, Wang Q, Lai J, Zhao J, Zhuo C, et al.
Cardiology
. 2021 Jul;
146(5):607-615.
PMID: 34237718
Background: Thyroid function is increasingly recognized as an important modifiable factor for atrial fibrillation (AF); however, it is unclear if the changes in thyroid hormones, even within the normal range,...
2.
Wang Q, Sun X, Zhuo C, Chen M, Wu M, Zhao J, et al.
Minerva Cardioangiol
. 2020 Feb;
68(3):224-233.
PMID: 32107893
Background: Hypertension is an important target for interventions to improve ablation outcome in atrial fibrillation (AF) patients. No studies to date have determined the blood pressure level at which AF...
3.
Wang Q, Zhuo C, Shang Y, Zhao J, Chen N, Lv N, et al.
Circ J
. 2019 Jun;
83(7):1463-1471.
PMID: 31178525
Background: The larger the left atrium anteroposterior dimension (LAD) and left atrium volume (LAV), the stronger the association with recurrent atrial fibrillation (AF) after radiofrequency catheter ablation (RFCA). Patients with...
4.
Lai J, Ge Y, Shao Y, Xuan T, Xia S, Li M
Coron Artery Dis
. 2015 May;
26(5):437-41.
PMID: 25968306
Background: Coronary artery calcification (CAC) is a pandemic condition in elderly patients with coronary artery disease (CAD) and associated with a worse prognosis. Although available data have shown an association...
5.
Lai J, Wu B, Xuan T, Xia S, Liu Z, Chen J
J Clin Med Res
. 2015 Apr;
7(6):446-52.
PMID: 25883708
Background: Patients with metabolic syndrome are at increased risk for cardiovascular disease. Combination lipid-lowering therapy is often needed in patients with metabolic syndrome and mixed dyslipidemia. The aim of this...
6.
Xia S, Li P, Chen Q, Armah M, Ying X, Wu J, et al.
Int J Nanomedicine
. 2014 Jun;
9:2607-17.
PMID: 24920898
Background: Conventional methods of preparing magnetoliposomes are complicated and inefficient. A novel approach for magnetoliposomes preparation was investigated in the study reported here. Methods: FeCl3/FeCl2 solutions were hydrated with lipid...
7.
Lai J, Wu B, Xuan T, Liu Z, Chen J
Lipids Health Dis
. 2014 Jan;
13:1.
PMID: 24382338
Background: Patients with mixed hyperlipidemia usually are in need of combination therapy to achieve low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG) target values for reduction of cardiovascular risk. This study...
8.
Lai J, Wu B, Sun J, Shang Y, Zhu J
Coron Artery Dis
. 2013 Sep;
24(7):566-71.
PMID: 23994882
Background: Sustained use of nitrates is associated with adverse effects on vascular function by increasing oxidative stress. It remains unclear whether oxidative stress impairs endothelial function in patients with coronary...
9.
Chen Y, Zhao S, Chen J, Lai J
J Clin Endocrinol Metab
. 2013 Jan;
98(2):E275-8.
PMID: 23293333
Objectives: The aim of the study was to evaluate the lipid-lowering effects and clinical safety of a natural hypolipidemic compound, coenzyme A (CoA) capsule, in Chinese patients with moderate dyslipidemia....
10.
Lai J, Zhou D, Xia S, Shang Y, Want L, Zheng L, et al.
Clin Cardiol
. 2009 Jan;
32(1):43-6.
PMID: 19143004
Background: Sex hormones play an important role in the development of cardiovascular disease. Testosterone and estradiol have been reported to be down-regulated in subjects with coronary artery disease and heart...